Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Allergies is Scopus-indexed (Q2, CiteScore 1.8), DOAJ. Published by Multidisciplinary Digital Publishing Institute (MDPI).
Checked against the index lists dated .
ISSN 2313-5786Verify ISSN ↗
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 27 / 57 | 53rd | Q2 |
| Immunology and Microbiology (miscellaneous) | 29 / 43 | 33rd | Q3 |
| Immunology and Allergy | 186 / 234 | 20th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q2, CiteScore 1.8.
Allergies is Q2 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 27 of 57), Q3 in Immunology and Microbiology (miscellaneous) (rank 29 of 43) and Q4 in Immunology and Allergy (rank 186 of 234), by CiteScore 2025.
Allergies is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.8, quartile Q2, 53rd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.290, quartile Q2, with an H-index of 7.
The publisher lists an article processing charge of about US$1,207 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Allergies is published by Multidisciplinary Digital Publishing Institute (MDPI). Its ISSN is 2313-5786.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Allergies has an h-index of 9 and a 2-year mean of 1.36 citations per paper (OpenAlex). Its Scopus CiteScore is 1.8, quartile Q2. On 2-year citations it ranks #24 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
Allergies published 45 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2023–2026), authors are most often from United States (25.3%), Brazil (9.2%) and Greece (9.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.